Notoginsenoside Ft1 acts as a Tgr5 agonist but Fxr antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice
Publication date: Available online 30 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Lili Ding, Qiaoling Yang, Eryun Zhang, Yangmeng Wang, Siming Sun, Yingbo Yang, Tong Tian, Zhengcai Ju, Linshan Jiang, Xunjiang Wang, Zhengtao Wang, Wendong Huang, Li Yang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 31, 2021 Category: Cancer & Oncology Source Type: research
Strategies to overcome drug resistance using SHP2 inhibitors
Publication date: Available online 28 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Meng Liu, Shan Gao, Reham M. Elhassan, Xuben Hou, Hao Fang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 29, 2021 Category: Cancer & Oncology Source Type: research
Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1
Publication date: Available online 27 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Na Kong, Xiaying Chen, Jiao Feng, Ting Duan, Shuiping Liu, Xueni Sun, Peng Chen, Ting Pan, Lili Yan, Ting Jin, Yu Xiang, Quan Gao, Chengyong Wen, Weirui Ma, Wencheng Liu, Mingming Zhang, Zuyi Yang, Wengang Wang, Ruonan Zhang, Bi Chen (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 28, 2021 Category: Cancer & Oncology Source Type: research
Gold nanorods-mediated efficient synergistic immunotherapy for detection and inhibition of postoperative tumor recurrence
Publication date: Available online 26 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yingying Zhang, Tiange Wang, Yu Tian, Chaonan Zhang, Kun Ge, Jinchao Zhang, Jin Chang, Hanjie Wang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 27, 2021 Category: Cancer & Oncology Source Type: research
Tricarbocyclic core formation of tyrosine-decahydrofluorenes implies a three-enzyme cascade with XenF-mediated sigmatropic rearrangement as a prerequisite
Publication date: Available online 26 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Zhiguo Liu, Wei Li, Peng Zhang, Jie Fan, Fangbo Zhang, Caixia Wang, Shuming Li, Yi Sun, Shilin Chen, Wenbing Yin (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 27, 2021 Category: Cancer & Oncology Source Type: research
Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications
Publication date: Available online 23 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Minshan Guo, Xiaojie Sun, Jiahui Chen, Ting Cai (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 24, 2021 Category: Cancer & Oncology Source Type: research
Influencing factors and strategies of enhancing nanoparticles into tumors in vivo
Publication date: Available online 24 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Mingming Zhang, Shan Gao, Dongjuan Yang, Yan Fang, Xiaojie Lin, Xuechao Jin, Yuli Liu, Xiu Liu, Kexin Su, Kai Shi (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 24, 2021 Category: Cancer & Oncology Source Type: research
Construction of acetyl-CoA and DBAT hybrid metabolic pathway for acetylation of 10-deacetylbaccatin III to baccatin III
Publication date: Available online 21 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Hao Wang, Boyong Zhang, Ting Gong, Tianjiao Chen, Jingjing Chen, Jinling Yang, Ping Zhu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 22, 2021 Category: Cancer & Oncology Source Type: research
Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
Publication date: Available online 22 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Jiashu Xie, Zhengqiang Wang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 22, 2021 Category: Cancer & Oncology Source Type: research
Pharmacological insights into autophagy modulation in autoimmune diseases
Publication date: Available online 22 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Ming-Yue Wu, Er-Jin Wang, Du Feng, Min Li, Richard D. Ye, Jia-Hong Lu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 22, 2021 Category: Cancer & Oncology Source Type: research
Discovery of a potent FKBP38 agonist that ameliorates HFD-induced hyperlipidemia via mTOR/P70S6K/SREBPs pathway
Publication date: Available online 22 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Ping-Ting Xiao, Zhi-Shen Xie, Yu-Jia Kuang, Shi-Yu Liu, Chun Zeng, Ping Li, E-Hu Liu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 22, 2021 Category: Cancer & Oncology Source Type: research
In vitro and in vivo correlation for lipid-based formulations: Current status and future perspectives
Publication date: Available online 21 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yanping Huang, Qin Yu, Zhongjian Chen, Wei Wu, Quangang Zhu, Yi Lu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 22, 2021 Category: Cancer & Oncology Source Type: research
Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release
Publication date: Available online 19 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Kefeng Zhai, Hong Duan, Wei Wang, Siyu Zhao, Ghulam Jilany Khan, Mengting Wang, Yuhan Zhang, Kiran Thakur, Xuemei Fang, Chao Wu, Jianbo Xiao, Zhaojun Wei (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 20, 2021 Category: Cancer & Oncology Source Type: research
A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine
Publication date: Available online 20 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Haiyu Xu, Yanqiong Zhang, Ping Wang, Junhong Zhang, Hong Chen, Luoqi Zhang, Xia Du, Chunhui Zhao, Dan Wu, Feng Liu, Hongjun Yang, Changxiao Liu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 20, 2021 Category: Cancer & Oncology Source Type: research
The cellular immunotherapy of integrated photothermal anti-oxidation Pd–Se nanoparticles in inhibition of the macrophage inflammatory response in rheumatoid arthritis
Publication date: Available online 4 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Chuping Zheng, Aiping Wu, Xinyun Zhai, Hong Ji, Zhikang Chen, Xu Chen, Xiyong Yu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 20, 2021 Category: Cancer & Oncology Source Type: research
